ENVESTNET ASSET MANAGEMENT INC - TURNING POINT THERAPEUTICS I ownership

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$448,000
+83.6%
5,954
+16.6%
0.00%
Q4 2021$244,000
+0.4%
5,106
+39.4%
0.00%
Q3 2021$243,000
-7.6%
3,663
+8.5%
0.00%
Q2 2021$263,000
-11.4%
3,376
+7.6%
0.00%
Q1 2021$297,000
-32.5%
3,138
-13.1%
0.00%
Q4 2020$440,000
+52.8%
3,613
+9.8%
0.00%
Q3 2020$288,0003,2910.00%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,392,297$291,501,0006.94%
Burrage Capital Management LLC 72,484$8,832,0006.73%
MPM BioImpact LLC 617,372$75,226,0006.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 113,541$13,816,0003.77%
Orbimed Advisors 2,745,327$334,518,0002.93%
SECTORAL ASSET MANAGEMENT INC 257,379$31,362,0002.21%
Parkman Healthcare Partners LLC 59,377$7,235,0001.85%
Nicholas Investment Partners, LP 183,676$22,381,0001.73%
EMERALD ADVISERS, LLC 357,038$43,505,0001.44%
EMERALD MUTUAL FUND ADVISERS TRUST 336,173$40,963,0001.42%
View complete list of TURNING POINT THERAPEUTICS I shareholders